Establishing, promoting, and communicating the highest standards of quality, integrity, and professionalism in the administration of workplace substance abuse prevention programs through education, training, and the exchange of ideas.

Edit This Favorite

David J. Kuntz, PhD, D-ABFT, D-FTCB

David Kuntz, PhD, is the Executive Director for Analytical Toxicology at Clinical Reference Laboratory in Lenexa, Kansas. Dr. Kuntz is Co-Responsible Person for the SAMHSA laboratory and the College of American Pathologists (CAP) forensic drug testing Scientific Director. He holds a laboratory director license in a number of states.

Dr. Kuntz received in Bachelor of Science in Pharmacy in1975, a MS in 1983 and a PhD in 1987. He further completed a post-doctoral program in biochemical toxicology at Washington State University and the University of Utah.

Dr. Kuntz is a Board Certified Toxicologist and is a national expert in urine adulteration and drug detection in urine, oral fluid, and sweat using GC/MS and LC/MS/MS. Dr. Kuntz has worked in workplace drug testing for the past 24 years and has testified extensively regarding drug use, interpretation, and adulteration of urine, oral fluid and sweat samples.

Dr. Kuntz is an inspector for the SAMHSA and CAP forensic drug testing programs and a past member of the national Drug Testing Advisory Board and the NLCP MSMS Standards Working Group. He currently serves on the editorial board for Clinical & Forensic Toxicology News and as a consultant to the MRO Examination Development Committee for the Medical Review Officer Certification Council (MROCC) and lecturer for AAMRO training courses.